Physician profile
Samir Agarwal
NPI 1851307615
$12,084.13
in general payments reported to CMS, 2019-2025
25 companies · $295 in 2025
The $295 reported for 2025 was less than what a typical Colon & Rectal Surgery provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,799 · 2020: $429 · 2022: $1,815 · 2023: $3,186 · 2024: $2,560 · 2025: $295.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,104 · Travel and Lodging: $2,937.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,104.09 |
| Travel and Lodging | $2,936.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $5,292.07 | 2019-2023 | Da Vinci Surgical System |
| Axonics, INC. | $2,437.29 | 2023-2024 | Axonics, Bulkamid |
| Mimedx Group, INC. | $1,693.25 | 2024 | |
| Medtronic, INC. | $1,586.74 | 2022-2025 | Signia, Interstim, Eea |
| Baxter Healthcare | $279.25 | 2020-2023 | Floseal, Tisseel |
| Stryker Corporation | $101.87 | 2023 | Spy-Phi System |
| Lexington Medical, INC. | $78.00 | 2025 | Aeon Endostapler & Echelon Flex Powered Stapler |
| Acell, INC. | $74.83 | 2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $67.35 | 2020-2023 | Gattex |
| Ethicon US, LLC | $56.62 | 2022-2025 | Echelon Endopath, Echelon; Endopath |
| Alfasigma USA, INC. | $54.73 | 2020 | |
| Kci USA, INC. | $48.22 | 2019 | |
| Davol INC. | $45.07 | 2023 | Phasix Mesh |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $38.61 | 2019-2020 | |
| Convatec INC. | $34.34 | 2020-2022 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Thd America, INC. | $31.72 | 2022 | |
| Merck Sharp & Dohme LLC | $29.79 | 2019-2020 | |
| Boston Scientific Corporation | $25.59 | 2022 | |
| Coloplast Corp | $19.02 | 2022 | |
| Olympus America INC. | $16.87 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $15.84 | 2020 | |
| Abbott Laboratories | $15.05 | 2025 | Eterna |
| Smith+Nephew, INC. | $14.65 | 2019 | |
| Hollister Incorporated | $14.64 | 2023 | New Image, Hollister |
| Braintree Laboratories, INC. | $12.72 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Samir Agarwal listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.